Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

DexCom, Inc. - Common Stock (NQ:DXCM)

84.67 -0.67 (-0.79%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2
...
28 29 30 31 32 33 34 35 Next >
Dexcom G6 Continuous Glucose Monitoring System Mobile App Now Available in Spanish
From Dexcom, Inc.
Via Business Wire
Nasdaq And 2 Other Stocks Insiders Are Selling
US gold futures traded mostly flat on Tuesday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
3 Biotech Stocks to Buy on the Dip
Biotech stocks have rebounded lately and are poised to keep surging, so it's a good time to buy biotech stocks on the dip. 
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
What 10 Analyst Ratings Have To Say About DexCom
DexCom (NASDAQ:DXCM) has observed the following analyst ratings within the last quarter: 
Via Benzinga
What Are Whales Doing With DexCom
A whale with a lot of money to spend has taken a noticeably bearish stance on DexCom. Looking at options history for DexCom (NASDAQ:DXCM) we detected 25 strange trades. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 15, 2022
  
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
  This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Here's How Much $100 Invested In DexCom 15 Years Ago Would Be Worth Today
DexCom (NASDAQ:DXCM) has outperformed the market over the past 15 years by 20.1% on an annualized basis producing an average annual return of 26.25%. Currently, DexCom has a market capitalization of... 
Via Benzinga
Dexcom Schedules Second Quarter 2022 Earnings Release and Conference Call for July 28, 2022 at 4:30 p.m. Eastern Time.
From DexCom, Inc.
Via Business Wire
Thoughts For Thursday: Which Way Through Uncertainty?
Markets are trying to maintain resistance levels generated from last week's rally, but finding the path to doing so is proving to be no easy matter. 
Via Talk Markets
Happy Birthday, iphone!
Exactly a decade and a half ago to the day, what is now the staple of the smartphone market first hit the shelves. 
Via Talk Markets
Here's How Much You Would Have Made Owning DexCom Stock In The Last 15 Years
DexCom (NASDAQ:DXCM) has outperformed the market over the past 15 years by 20.9% on an annualized basis producing an average annual return of 27.35%. Currently, DexCom has a market capitalization of... 
Via Benzinga
Comparing Fitbits To Medical Devices? This Company Says Things Aren't Even Close
The health and wellness industry focused on the well-being of the body, mind and spirit has captured the globe's attention. According to management consulting firm, Mckinsey & Co., the global wellness... 
Via Benzinga
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $16,000 Today
DexCom (NASDAQ:DXCM) has outperformed the market over the past 5 years by 64.52% on an annualized basis producing an average annual return of 74.42%. Currently, DexCom has a market capitalization of... 
Via Benzinga
Relief May Soon Be On The Way For Diabetes Sufferers Weary Of Constant Pin Pricks, According To This Company
Last year was the 100th anniversary of the discovery of insulin, which was instrumental in improving people's lives around the world. 
Via Benzinga
7 Undervalued Penny Stocks to Buy for Massive Gains
These seven undervalued penny stocks each have the potential to pay off for investors down later down the road. 
Via InvestorPlace
Here's Why These 14 Companies Did A Stock Split In 2022
A stock split's main purpose is to make a company's shares more appealing to potential investors. By raising the number of outstanding shares, it improves a company's liquidity. Stock splits do not... 
Via Benzinga
Markets Rise Amid Strength In Tech, Software
U.S. indices finished Thursday’s trading session higher. Overall tech and software sector strength as well as strong first-quarter results from Mongodb Inc (NASDAQ: MDB) lifted markets higher for the... 
Via Benzinga
Dexcom to Showcase Expanded CGM Portfolio and Industry-leading Connectivity at 82nd Scientific Sessions of the American Diabetes Association
From DexCom, Inc.
Via Business Wire
Here's How Much You Would Have Made Owning DexCom Stock In The Last 15 Years
DexCom (NASDAQ:DXCM) has outperformed the market over the past 15 years by 22.06% on an annualized basis producing an average annual return of 28.95%. Currently, DexCom has a market capitalization of... 
Via Benzinga
DexCom Dispels Rumor of Active Merger Talks as Insulet Stock Drops
"Active conversations" about a merger are not presently taking place between DexCom Inc. (DXCM), 7.28 percent, and the S&P 500 
Via Best Stocks
Dexcom Pops After Insulet Buyout Rumor Shakes Up Diabetes Stocks
The deal would have been transformative, but may have limited teamwork in the space. 
Via Investor's Business Daily
Dexcom Issues Statement on Recent Market Speculation
From DexCom, Inc.
Via Business Wire
Norwegian Cruise Line And Caesars Entertainment Lead The S&P 500 Lower: Today's Winners And Losers
U.S. indices finished Tuesday's trading session lower amid a continued sell-off in stocks. 
Via Benzinga
How The Rumored Dexcom-Insulet Marriage Could Rock The Entire Diabetes Space
One analyst called the rumored deal "transformative," but says the timing is unfavorable. 
Via Investor's Business Daily
PODD Stock Pops 7% as DexCom Considers Insulet Corporation Acquisition
Insulet (PODD) stock is heading higher on Tuesday as investors react to reports that DexCom (DXCM) is considering acquiring the company. 
Via InvestorPlace
Dexcom In Talks To Acquire Insulet, Create a Giant In Diabetes Devices: Bloomberg
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on
Good morning, trader! We're jumping into trading on Tuesday with an overview of the biggest pre-market stock movers this morning! 
Via InvestorPlace
Dexcom Announces Upcoming Conference Presentation
From DexCom, Inc.
Via Business Wire
< Previous 1 2
...
28 29 30 31 32 33 34 35 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.